Related Experiment Video
Updated: May 31, 2026

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters
Published on: May 18, 2014
Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells
Louise T Dalgaard1, Peter Thams, Louise W Gaarn
1Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. ltd@ruc.dk
Abstract:
Fatty acid-induced damage in pancreatic β-cells is assumed to play an important role in the development of type 2 diabetes. Lactogens (prolactin, placental lactogen and growth hormone) improve β-cell survival via STAT5 activation but the molecular targets are incompletely characterized. The aim of this study was to examine the effect of human growth hormone (hGH) on mRNAs of fatty acid transport and binding proteins expressed in pancreatic β-cells, and to examine this in relation to β-cell survival after exposure to fatty acids. hGH decreased mRNA levels of FAT/CD36, whereas mRNAs of GPR40, FASN, FABP2, FATP1 and FATP4 were unchanged. RNAi against FAT/CD36 decreased fatty acid-induced apoptosis. Over-expression of constitutively active STAT5 was able to mimic hGH's suppression of FAT/CD36 expression, whereas dominant negative STAT5 was unable to block the effect of hGH indicating that STAT5 did not bind directly to the FAT/CD36 promoter. The hGH-mediated suppression of FAT/CD36 mRNA was associated with a decrease in palmitate uptake and fatty acid-induced basal hyper-secretion of insulin resulting in improved glucose-stimulated insulin secretion. This study suggests that hGH can protect β-cells against fatty acid-induced damages.
Insights
Human growth hormone (hGH) protects pancreatic beta cells from fatty acid damage by reducing FAT/CD36. This improves insulin secretion, offering a potential therapeutic strategy for type 2 diabetes.
Area of Science:
- Endocrinology
- Molecular Biology
- Diabetes Research
Background:
- Fatty acid-induced damage to pancreatic beta cells contributes to type 2 diabetes.
- Lactogens, including human growth hormone (hGH), enhance beta cell survival through STAT5 activation, but their specific molecular targets remain unclear.
Purpose of the Study:
- To investigate the impact of hGH on the expression of fatty acid transport and binding proteins in pancreatic beta cells.
- To correlate these changes with beta cell survival following fatty acid exposure.
Main Methods:
- Quantitative analysis of mRNA levels for various fatty acid-related proteins.
- RNA interference (RNAi) to target FAT/CD36.
- Manipulation of STAT5 signaling pathways (constitutively active and dominant-negative forms).
- Measurement of palmitate uptake and insulin secretion.
Main Results:
- hGH significantly reduced mRNA levels of FAT/CD36 but did not affect GPR40, FASN, FABP2, FATP1, or FATP4.
- Silencing FAT/CD36 using RNAi decreased fatty acid-induced apoptosis.
- STAT5 activation mimicked hGH's effect on FAT/CD36, but STAT5 inhibition did not block hGH's action, suggesting indirect STAT5 involvement.
- hGH-induced reduction in FAT/CD36 correlated with decreased palmitate uptake and improved glucose-stimulated insulin secretion.
Conclusions:
- hGH protects pancreatic beta cells from fatty acid-induced damage by downregulating FAT/CD36 expression.
- This mechanism involves reduced fatty acid uptake and improved insulin secretion, suggesting a protective role for hGH in diabetes.
Related Concept Videos
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Feedback Loops
Type II Diabetes II: Pathophysiology

